Neoadjuvant approach as a platform for treatment personalization: focus on her2-positive and triple-negative breast cancer

Breast cancer (BC) represents the most frequently diagnosed tumor in women worldwide[1]. Systemic treatments for early-BC (EBC) have been historically administered in the adjuvant setting, however, in the last decades, the strategy of administering systemic therapy before surgery – in the so-called neoadjuvant setting – has been increasingly adopted, in order to expand locoregional treatment
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Tags: Hot Topic Source Type: research